Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP10A-DT is referred to as a "divergent transcript" associated with the ATP10A gene, but no detailed scientific information is available about its molecular function, classification, or biological role. The ATP10A gene itself encodes an aminophospholipid-transporting ATPase (also called a phospholipid flippase) involved in translocating phospholipids such as phosphatidylcholine across the plasma membrane, affecting membrane dynamics and cell signaling. However, the term "ATP10A-DT" does not appear to refer to the canonical protein target (ATP10A) and instead may refer to a long non-coding RNA (lncRNA) or other noncoding transcript that is transcribed in the opposite (divergent) direction from the ATP10A gene locus. There is no evidence in the current literature that "ATP10A-DT" is a protein-coding gene, therapeutic target, or even a well-characterized molecular entity. "ATP10A-DT" likely represents a bioinformatic or transcriptomic entry (e.g., from BioGPS or similar databases), not a validated therapeutic target or functional protein/gene product. For clinical, pharmacological, or translational research, the correct target is ATP10A (ATPase phospholipid transporting 10A), not "ATP10A-DT". The latter remains poorly characterized and should be flagged as "is_incorrect" for the purposes of target databases or therapeutic research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP10A divergent transcript (ATP10A-DT).